scott@vtx-cpd.com
Forum Replies Created
-
AuthorPosts
-
Replying to Alison M. 05/05/2025 - 19:51
Hi Alison,
Lovely to meet you, and welcome back to the world of medicine (the feline kind, not the CBeebies kind). Congratulations on your second daughter! I imagine the return to work is a bit of a whirlwind, but hopefully a refreshing change of pace too.
Looking forward to learning alongside you.
Best,
Scott
Replying to Helen S. 05/05/2025 - 14:56
So many great moments, but this one sticks out!
Scott x
Replying to Sara Jackson 05/05/2025 - 14:26
What a lovely photo!
Let me know how you get on with the course. Thank you so much for continuing to support what we do.
Scott x
Replying to Rachel H. 05/05/2025 - 13:31
Hi Rachel,
Thanks so much for getting in touch. This is a great case to think through, and I really like your plan. I agree that there are a few red flags that suggest she may not have classic Addison’s, and it makes sense to reassess the diagnosis now that you’ve inherited the case.
The main concern for me is the timing of the ACTH stimulation test. From what you described, the test was performed just five days after stopping prednisolone. Although pred doesn’t interfere analytically with cortisol assays, it absolutely can cause suppression of the hypothalamic-pituitary-adrenal (HPA) axis through feedback inhibition, and five days may not have been long enough to avoid that. Recent data has added some nuance to our understanding here. A 2024 prospective study by Del Baldo et al. looked at HPA axis recovery in 20 client-owned dogs treated with intermediate-acting glucocorticoids like pred or methylpred. They found that while the median time to recovery was just three days, some dogs took much longer, and in one case, the HPA axis remained suppressed for over 18 weeks. That dog showed flat ACTH stim responses for months before eventually regaining a measurable post-stim cortisol. So even though most dogs bounce back quickly, there is significant variability, and a flat cortisol result five days post-pred cannot be considered definitively diagnostic.
The other major factor is the fact that she has never had electrolyte abnormalities. True primary hypoadrenocorticism almost always involves some degree of electrolyte derangement, either at diagnosis or over time. In contrast, dogs with atypical Addison’s have glucocorticoid deficiency only and retain normal sodium and potassium because their mineralocorticoid axis is intact. The fact that she’s needed her Zycortal dose reduced at every recheck, with normal electrolytes throughout, strongly suggests that she may not have any clinically relevant mineralocorticoid deficiency at all.
I think your current approach of continuing the Zycortal but gradually tapering it based on electrolyte monitoring is a very reasonable one. If you reach a dose that’s very low, for example below 0.5 mg/kg, and electrolytes are still normal, I’d absolutely consider a trial off Zycortal. You could skip the next injection, then recheck electrolytes at two to three weeks and again at four to five weeks to watch for any delayed shifts. If her sodium and potassium remain within normal limits and she’s clinically stable, it would support that she does not need mineralocorticoid supplementation.
If you wanted to go a step further, once she’s stable off Zycortal, you could consider repeating the ACTH stimulation test after a longer washout from higher-dose steroids. Including an endogenous ACTH measurement at that time would be helpful too. A truly Addisonian dog should have an elevated endogenous ACTH with a flat cortisol response, whereas a dog with prior suppression will typically have a low to low-normal ACTH as the pituitary axis reawakens.
If she does well off Zycortal, you can just continue low-dose prednisolone long-term and manage her as an atypical Addisonian, assuming her clinical signs remain controlled. Or, if the repeated testing points away from Addison’s altogether, you may even be able to wean her entirely.
You’re already handling this really thoughtfully, and I think you’re absolutely on the right track. Let me know how she gets on or if you want to chat further down the line.
Best,
Scott 🙂
Full reference:
Del Baldo F, Corsini A, Tardo AM, et al. Hypothalamic–pituitary–adrenal axis recovery after intermediate-acting glucocorticoid treatment in client-owned dogs. Journal of Veterinary Internal Medicine. 2024;38(2):942–950. doi:10.1111/jvim.16979
Replying to Steph Sorrell 05/05/2025 - 08:56
Hey Steph!
So lovely to see you here! Thank you for being a part of this!
Scott x
Replying to Samantha T. 07/05/2025 - 19:14
Welcome Sam!
Thank you for your brilliant contribution, and thank you for the cute kitten picture!
Scott 🙂
Replying to Christina Frigast 08/05/2025 - 09:36
I think owners hate the idea of and E-tube… but most in my experience cope much better than they think they will!
Scott 🙂
Replying to Christina Frigast 08/05/2025 - 09:41
Sadly these are all on the more expensive end of treatments!
Thanks again for sharing all these brilliant thoughts.
Scott 🙂
Replying to Christina Frigast 08/05/2025 - 09:47
Good news!
Thank you again for sharing these brilliant cases!
I hope you are having a great week.
Scott 🙂
Replying to Rodolfo L. 08/05/2025 - 11:38
Rodolfo!
Thank you so much for joining us and for being part of the course!
We are very lucky to get to work with you!
Scott 🙂
Replying to Yvonne McGrotty 03/05/2025 - 16:29
Thanks so much, Yvonne. Really appreciate your perspective, and completely agree that the benefits of reducing stress with gabapentin often outweigh the theoretical risks, especially given how much physiologic disruption severe stress can cause. Thanks also for sharing the Stevens et al. paper, a great reference to have on hand.
Have a great week!
Scott
Replying to Christina Frigast 04/05/2025 - 11:04
Hi Christina,
That’s a great question about FIP and transfusions. In general, I do think blood transfusions can have a role in selected cases, particularly when the anaemia is moderate to severe and clearly affecting clinical status. That said, many cats with FIP develop a non-regenerative, inflammatory anaemia that they tolerate reasonably well for some time. If the cat is bright, eating, and stable, I’d often hold off unless there is functional compromise or clear evidence of progression.
Your decision to monitor conservatively, especially with xenotransfusion as the only option, sounds entirely appropriate. Some referral hospitals may opt for early transfusion as a stabilising measure if further procedures or stressors are anticipated, but I think either approach can be valid depending on the context.
I also think the availability of FIP treatment really changes the equation. With GS products and remdesivir now accessible, we’re often able to initiate therapy promptly and see rapid improvement, which can stabilise haematologic parameters and help avoid interventions like transfusion altogether. If antiviral therapy is within reach, I would lean toward starting that and reserving transfusion for cases that are clearly decompensating.
Thanks again for raising such a thoughtful point.
All the best,
Scott 🙂
Replying to Christina Frigast 04/05/2025 - 11:10
Hi Christina,
Yes, in that situation I probably would have used co-amoxiclav IV at 20 mg/kg q8h, even with the Clamoxyl LA on board, particularly if I had growing concern for sepsis or deterioration. While it’s not ideal to overlap two β-lactams, the clinical priority in a potentially decompensating patient shifts toward ensuring adequate plasma concentrations and broad-spectrum IV coverage. Clamoxyl LA can be unpredictable in terms of achieving therapeutic levels in more severe or rapidly evolving infections, especially given its depot nature.
As for the marbofloxacin, this referenced dose is also higher than I would normally use. The 2 mg/kg IV dose is what’s commonly referenced in formularies for standard use in dogs, and I think it was entirely reasonable here. If you were treating a more resistant gram-negative infection or concerned about achieving higher tissue levels (e.g. with prostatitis, pyelonephritis, or septic peritonitis), there is some precedent for higher-end dosing (up to 4 mg/kg), but I would generally only consider that with strong justification or lack of alternative agents. For most systemic use where enrofloxacin isn’t an option, 2 mg/kg IV is a solid choice.
I hope you have had a great weekend,
Scott 🙂
Replying to Christina Frigast 04/05/2025 - 11:36
Hi Christina,
That all makes perfect sense, and I completely agree. Feeding tubes remain underutilised in many settings, even though early nutritional support has clear evidence for improving outcomes and potentially shortening hospital stays. While cost is often cited as a barrier, it rarely reflects the true balance between timely intervention and the morbidity associated with delayed nutritional support.
The recent JAVMA paper by Freilich and Jugan (2025) underscores this point. In their retrospective review of 295 dogs and cats, the median time to feeding tube placement was two days, and only 18 percent of patients had specific feeding instructions recorded in the medical record. Earlier placement—particularly of nasogastric tubes—and weekday admissions were associated with shorter delays, while initial use of oesophageal tubes or weekend admission prolonged time to feeding initiation.
Regarding contraindications, I tend to avoid nasogastric or nasoesophageal tubes in patients with active vomiting or uncontrolled regurgitation, significant nasal or upper airway trauma, marked coagulopathy (especially if epistaxis could be difficult to control), reduced mentation without a protected airway, or high aspiration risk in the absence of safe positioning. That said, for borderline cases, I’ve used very slow trickle feeding via syringe driver to monitor tolerance and reduce the risk of reflux or regurgitation, which can be helpful as a stepwise approach.
The 2024 JSAP study by Camacho and Humm provides further reassurance about the safety of both nasoesophageal and nasogastric tubes. In their randomised controlled trial of 97 animals, tube misplacement into the respiratory tract occurred in just 3.1 percent of cases, and most complications during placement were minor. There were no significant differences in vomiting or regurgitation rates between the two tube types once placed. Although radiography remains the gold standard for confirming placement, the study noted that negative pressure at the thoracic inlet and capnography may offer useful adjunctive confirmation.
However, rare but serious complications do occur. A 2023 JAVMA study by Odunayo et al. described 13 dogs that developed pneumothorax following NG tube misplacement into the tracheobronchial tree. Of these, five died or were euthanised, and most required thoracocentesis or thoracostomy tube placement. The overall incidence was low (0.3 percent of nearly 4,800 placements), but it highlights the need for vigilance and rapid response to respiratory compromise following placement.
As for oesophagostomy tubes, the 2019 JVIM study by Nathanson et al. reviewed complications in 225 patients (123 cats, 102 dogs). They reported an overall complication rate of 44 percent, with similar rates in cats and dogs. Most were minor, but infectious complications requiring surgical debridement occurred in a subset, and three patients were euthanised due to severe tube-related issues. No particular patient characteristics predicted complications, so consistent monitoring and client education remain critical for managing these patients safely at home.
Altogether, I think the evidence supports earlier and more confident use of feeding tubes, ideally starting with NG or NE in hospital and transitioning to E-tubes if prolonged support is expected.
I always say to owners that the placement of an oesophageal feeding tube often gets you out the hospital quicker!
All the best,
Scott 🙂
Hi Kath,
Thanks for starting such a great discussion. One thing I’ve always wondered about is the potential for CO₂ buildup in makeshift oxygen cages. I know commercial units are designed with airflow and venting in mind, but when we’re improvising with taped-off crates or incubators, how much of a concern is that accumulation? Have you ever seen clinical signs that made you suspect CO₂ was becoming an issue, or do you take any specific steps to prevent it when using DIY setups? I’d be really interested to hear your thoughts on that.
Scott
-
AuthorPosts